Navigation Links
WuXi PharmaTech Completes Acquisition of AppTec
Date:1/31/2008

SHANGHAI, China, Jan. 31 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX) today announced the completion of its acquisition of AppTec Laboratory Services, Inc., a US-based service provider for the biopharmaceutical and medical device industries. AppTec offers testing, contract research and development, and cGMP biologics manufacturing services from a highly differentiated, fully integrated platform.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The combined company brings together complementary service offerings and expertise to create a broad platform covering both chemistry and biologics, which allows WuXi PharmaTech to provide value-added services to our customers in the pharmaceutical, biotechnology and medical device industries.

"We are pleased to have completed this significant acquisition which immediately adds biologics capabilities and expertise to WuXi PharmaTech's existing capabilities, gains a significant U.S. operational footprint for WuXi PharmaTech and expands our U.S. customer base, with further opportunities to increase our market position," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. "This acquisition further solidifies our leadership position as the premier and preferred drug R&D service partner for pharmaceutical, biotechnology and medical device companies."

"The management teams and dedicated employees of both companies are very enthusiastic about the prospects of the combined company," commented Mr. Edward Hu, COO of WuXi PharmaTech. "This is an acquisition of capabilities that we believe will drive our future growth by positioning WuXi as a high quality global drug R&D service collaborator with both small and large molecules expertise."

About WuXi PharmaTech

Founded in 2000, Shanghai-based WuXi PharmaTech is the leading China-based pharmaceutical and biotechnology R&D outsourcing comp
'/>"/>

SOURCE WuXi PharmaTech
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
2. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
3. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
4. WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
5. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
6. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
7. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
8. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
9. WuXi PharmaTech Announces Second Quarter 2007 Results
10. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
11. Max Nutrition, Inc. Completes Share Exchange with American Spring Pharmaceutical, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...bleEnergyCorp.announcedtodaythatthecompanyandtheOd...arded$2millionbyWashingtonState,sCommunityEconomic...hiptoconstructthestate,sfirstspecialtybiochemicalb...twillsignificantlyspeedthedevelopmentofourbiorefin...eMarbleEnergyCEOKellyOgilvie."WearegratefultotheGo...
(Date:11/24/2009)...all/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobals...atithassubmittedaMAAtotheEuropeanMedicinesAgencyfo...herapyindevelopment,forthetreatmentofType1Gaucherd...lucerasealfathathasbeensubmitted,withprevious,subm...globalsupplyshortageofthecurrentlyapprovedandmarke...
(Date:11/24/2009)...Customers with Partners Validated to Process and A... , Ottawa, ON (PRWEB) Nov...r of products for biological sample collection, st...ew global partner program. The program offers sign...munity and is designed to help partners scale and ...
(Date:11/23/2009)...rigami very high-tech origami. , Researchers at ...que for fabricating three-dimensional, single-crys...ling photolithography and a self-folding process d...y a few microns thick, offer mechanical bendabilit...same material. , "This is a completely different ...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
... /PRNewswire-FirstCall/ - Angiotech Pharmaceutical...d that its corporate partner, Boston Scientific Co...comes from a substudy of patients with left main c... Express(2)(R) Paclitaxel-Eluting Coronary Stent S...k SYNTAX trial, the first randomized, controlled c...
...ay 19 In an eleventh-hour attempt to smear Ted K...has issued a press release claiming that there was...ichard Rosenbloom, a key staff member of a subsidi...oup of dissident shareholders who have offered the...lection at the annual meeting scheduled for Wednes...
...w Projects Approved in Atlanta , , ATLANTA, May ...biotechnology convention, the Kansas Bioscience Au...investments as part of a $581 million initiative t...ate. , , The funding decisions made at the Bio In...ers of innovation in biomaterials and plant biolog...
Other Biology Technology:SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 2SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 3SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 4SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 5In Eleventh-Hour Smear Attempt, Quigley Management Sacrifices Key Employee of its Pharma Division 2In Eleventh-Hour Smear Attempt, Quigley Management Sacrifices Key Employee of its Pharma Division 3As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 2As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 3As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 4
(Date:11/23/2009)...HAM, Ala. A new study by University of Alabama at... index (BMI) and co-existing medical conditions (c... observed among African-Americans compared to Cauc...blished online Nov. 23 in Cancer , a journal of t...tes that although BMI and co-morbidity are indepen...
(Date:11/23/2009)...like frogs and toads have existed for 360 million ...a new aquatic fungus is threatening to make many o...ember issue of Microbiology Today . , The fung...nd to be associated with waves of amphibian extinc...ia in the 1990,s. Bd infects over 350 amphibian sp...
(Date:11/23/2009)...ts have revealed how environmental irritants such ...to cough, in research published today in the Amer...cine . The authors of the study, from Imperial Col...ified the reaction inside the lungs that can trigg... irritants in the air. They suggest that their fin...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Research reveals exactly how coughing is triggered by environmental irritants 2Video 3A Anthem Blue Cross and the California Governors Council on Physical Fitness and Sports Launch the Live Like a Champion Tour 57982 1Video 3A Anthem Blue Cross and the California Governors Council on Physical Fitness and Sports Launch the Live Like a Champion Tour 57982 2Video 3A Anthem Blue Cross and the California Governors Council on Physical Fitness and Sports Launch the Live Like a Champion Tour 57982 3Osseon Signs International Distribution Agreement With MBA Incorporado 57980 1Osseon Signs International Distribution Agreement With MBA Incorporado 57980 2Osseon Signs International Distribution Agreement With MBA Incorporado 57980 3GHX Joins the Oracle PartnerNetwork 57978 1GHX Joins the Oracle PartnerNetwork 57978 2GHX Joins the Oracle PartnerNetwork 57978 3
... of the biggest questions in modern oceanography i...arine biologists at the Monterey Bay Aquarium Rese...that helps answer this question, at least for anim...f Central California. After analyzing hundreds of ...leagues found that "sinkers"-the cast-off mucus ne...
...mas C. Quinn, M.D., a Johns Hopkins physician and ... 25 years leading major efforts to combat HIV and ...trategies and resources to confront the rapid "fem...sor of infectious diseases at Hopkins and a senior... and Infectious Disease, reports that women have i...
... of minuscule devices to spot cancer markers could... University researchers have found that molecular ...ody are readily detected in blood scanned by speci...cancer markers constitute only one hundred-billion...ddition to this exceptional accuracy and sensitivi...
Other Biology News:'Sinkers' provide missing piece in deep-sea puzzle 2'Sinkers' provide missing piece in deep-sea puzzle 3'Sinkers' provide missing piece in deep-sea puzzle 4AIDS expert says global strategy needed to combat feminization of HIV/AIDS 2AIDS expert says global strategy needed to combat feminization of HIV/AIDS 3Nanowires can detect molecular signs of cancer, scientists find 2Nanowires can detect molecular signs of cancer, scientists find 3
Custom siRNA, standard purity, annealed from Ambion
...es the premium quality siRNAs you need for your ge...y ordered online by providing either the 19-21 bas...ntisense siRNA sequences. (Also check out Ambion&#...ned siRNAs, which are already designed for you.) F...
Sheep Prolactin from Cell Sciences
Goat Anti-Human SCP3 / SYCP3 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: